Phytoestrogens과 골대사 = Phytoestrogens and Bone Metabolism

다국어 초록 (Multilingual Abstract)

Although most gynecologists had prescribed estrogen with or without progestin for their menopausal patients before the publication of Women’s health Initiative (WHI) trial findings, only 35 to 40% of women ever started hormone therapy (HT) and many discontinued it, because of perceived side effects and discomfort. HT will not likely to be regularly prescribed in the future given the recommendations by several groups against long-term use for chronic diseases after the release of the findings of the WHI. Consequently, many postmenopausal women have turned to botanical dietary supplements containing phytoestrogen as an alternative to HT. Although there are numerous studies in the literature over the last decade trying to address the efficacy of phytoestrogens on bone health in animal models and in humans, the efficacy of phytoestrogens as bone-protective agents in vivo remains unclear. Differences in the bioactivities of individual phytoestrogens, differences in bioavailability and metabolism of phytoestrogens within different study populations, and imprecise reporting of the form and dose of phytoestrogens provided in intervention studies may have leaded to the disparity in study results. However, the preventive effect of phytoestrogens for bone loss is promising. This review discusses the effects of phytoestrogens on bone metabolism and their roles on the prevention and treatment of postmenopausal osteoporosis.

참고문헌 (Reference)

1 Kritz-Silverstein, "Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women" 11 : 69-78, 2002

2 Fanti P, "The phytoestrogen genistein reduces bone loss in short-term ovariectomised rats" 8 : 274-281, 1998

3 Theoleyre S, "The molecular triad OPG/RANK/ RANKL: involvement in the orchestration of pathophysiological bone remodeling" 15 : 457-475, 2004

4 Atkinson C, "The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial" 79 : 326-333, 2004

5 Spence LA, "The effect of soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomized crossover study" 81 : 916-922, 2005

6 Cotter AA, "The effect of oestrogen and dietary phyto-oestrogens on transepithelial calcium transport in human intestinal-like Caco-2 cells" 89 : 755-765, 2003

7 Dang ZC, "The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis" 19 : 853-861, 2004

8 Wuttke W, "The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers" 44 : S67-S77, 2003

9 Fuller K, "TRANCE is necessary and sufficient for osteoblastmediated activation of bone resorption in osteoclasts" 188 : 997-1001, 1998

10 Suh KS, "Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E-2 in osteoblastic cells" 63 : 209-215, 2003

11 Picherit C, "Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomised rats" 131 : 723-728, 2001

12 Federici E, "Soybean extract and its isoflavones, genistein and daidzein, stimulate BMP-2 expression and bone formation by inhibiting the mevalonate pathway in osteoblast cells" 34 (34): S4-S4, 2004

13 Arjmandi BH, "Soy protein: its effects on intestinal calcium transport, serum vitamin D, and insulinlike growth factor-I in ovariectomized rats" 70 : 483-487, 2002

14 Potter S, "Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women" 68 : 1375S-1379S, 1998

15 Dae Won Kim, "Soy Isoflavones Mitigate Long-Term Femoral and Lumbar Vertebral Bone Loss in Middle-Aged Ovariectomized Mice" 한국식품영양과학회 12 (12): 536-541, 2009

16 Arjmandi BH, "Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats" 68 (68): 1358S-1363S, 1998

17 Kim MK, "Relationships of urinary phytooestrogen excretion to BMD in postmenopausal women" 56 : 321-328, 2002

18 Song KB, "Prevalence of daidzein- metabolizing phenotypes differs between Caucasian and Korean American women and girls" 136 : 1347-1351, 2006

19 Ibarreta D, "Possible health impact of phytoestrogens and xenoestrogens in food" 109 : 161-184, 2001

20 Nettleton JA, "Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer" 134 : 1998-2003, 2004

21 Lagari VS, "Phytoestrogens and bone health" 17 : 546-553, 2010

22 Lee Y, "Physiological concentrations of genistein stimulate the proliferation and protect against free radical-induced oxidative damage of MC3T3-E1 osteoblast-like cells" 21 : 1287-1293, 2001

23 Dang ZC, "Peroxisome proliferator-activated receptor gamma (PPAR gamma) as a molecular target for the soy phytoestrogen genistein" 278 : 962-967, 2003

24 Brink E, "PHYTOS Investigators. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study" 87 : 761-770, 2008

25 Hotchkiss CE, "Multigenerational exposure to genistein does not increase bone mineral density in rats" 37 : 720-727, 2005

26 Chen XW, "Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogenreceptordependent pathway" 295 : 417-422, 2002

27 Lydeking-Olsen E, "Isoflavone- Rich Soymilk Prevents Bone Loss in the Lumbar Spine of Postmenopausal Women: A Two-Year Study" 132 : 582S-, 2002

28 Alexandersen P, "Ipriflavone in the Treatment of Postmenopausal Osteoporosis: A Randomized Controlled Trial for the Ipriflavone Multicenter European Fracture Study" 285 : 1482-1488, 2001

29 James P, "Influence of dietary protein and phyto-oestrogens on bone mineralization in the young rat" 22 : 385-392, 2002

30 Mei J, "High Dietary Phytoestrogen Intake Is Associated with Higher Bone Mineral Density in Postmenopausal but Not Premenopausal Women" 86 : 5217-5221, 2001

31 Okamoto F, "Genistein, a soybean isoflavone, inhibits inward rectifier K+ channels in rat osteoclasts (Abstract)" 51 : 501-509, 2001

32 Pan W, "Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrowculture" 94 : 307-316, 2005

33 Li BB, "Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation" 26 : 780-786, 2003

34 Frankenfeld CL, "Familial correlations, segregation analysis and nongenetic correlates of soy isoflavone-metabolising phenotypes" 229 : 902-913, 2004

35 Seidlova-Wuttke D, "Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta" 149 : 351-362, 2003

36 Wangen KE, "Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women" 85 : 3043-3048, 2000

37 Koyama I, "Effects of natto (fermented soybean; made from isoflavone- rich soybean) supplemented with zinc and calcium on bone density and bone metabolic markers of postmenopausal women" 134 (134): S1288-S1289, 2004

38 Chen X, "Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation" 14 : 342-349, 2003

39 Chen XW, "Effects of genistein on expression cell of bone markers during MC3T3-E1 osteoblastic differentiation" 14 : 342-349, 2003

40 Yamaguchi M, "Effect of polyphenols on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro" 24 : 1437-1439, 2001

41 Morabito N, "Effect of genistein and Hormone replacement therapy on bone loss in early postmenopausal women: A randomized doubleblind placebo-controlled study" 17 : 1904-1912, 2002

42 Chiang SS, "Effect of bioactive compounds in lactobacilli-fermented soy skim milk on femoral bone microstructure of aging mice" 92 : 328-335, 2012

43 Horiuchi T, "Effect of Soy Protein on Bone Metabolism in Postmenopausal Japanese Women" 11 : 721-724, 2000

44 Rassi CM, "Down-regulation of osteoclast differentiation by daidzein via caspase 3" 17 : 630-638, 2002

45 Picherit C, "Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat" 85 : 307-316, 2001

46 Alcantara EH, "Diosgenin stimulates osteogenic activity by increasing bone matrix protein synthesis and bonespecific transcription factor Runx2 in osteoblastic MC3T3-E1 cells" 22 : 1055-1063, 2011

47 Nakai M, "Dietary soy protein and isoflavones: no effect on the reproductive tract and minimal positive effect on bone resorption in the intact female Fischer 344 rat" 43 : 945-949, 2005

48 Greendale G, "Dietary Soy Isoflavones and Bone Mineral Density: Results from the Study of Women's Health Across the Nation" 155 : 746-751, 2002

49 Huang YF, "Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones" 90 : 3956-3962, 2005

50 Harkness L, "Decreased bone resorption with soy isoflavone supplementation in postmenopausal women" 13 : 1000-1007, 2004

51 Wu XT, "Coumestrol promotes proliferation and osteoblastic differentiation in rat bone marrow stromal cells" 90 : 621-628, 2009

52 Kuiper G, "Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β" 138 : 863-870, 1997

53 Uesugi T, "Comparative study on reduction of bone loss and lipid metabolism, abnormality in ovariectomized rat by soy isoflavone, daidzein, genistein, and glycytin" 24 : 368-372, 2001

54 Chiang SS, "Benificial effects of phytoestrogens and their metabolites produced by intestinal microflora on bone health" 97 : 1489-1500, 2013

55 Chiang SS, "Antiosteoporotic effects of Lactobacillus fermented soy skim milk on bone mineral density and the microstructure of femoral bone in ovariectomized mice" 59 : 7734-7742, 2011